Estrella Immunopharma Inc. (NASDAQ: ESLA)
$1.2500
+0.1200 ( +14.68% ) 12.5K
Estrella Immunopharma Inc is a preclinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer.
Market Data
Open
$1.2500
Previous close
$1.1300
Volume
12.5K
Market cap
$36.90M
Day range
$1.0600 - $1.2350
52 week range
$0.6300 - $3.2300
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | Dec 16, 2024 |
8-k | 8K-related | 15 | Dec 06, 2024 |
8-k | 8K-related | 14 | Nov 26, 2024 |
8-k | 8K-related | 14 | Nov 25, 2024 |
10-q | Quarterly Reports | 67 | Nov 14, 2024 |
8-k | 8K-related | 15 | Nov 07, 2024 |
8-k/a | 8K-related | 14 | Nov 07, 2024 |
10-k/a | Quarterly Reports | 16 | Oct 28, 2024 |
10-k | Annual reports | 108 | Sep 27, 2024 |
3 | Insider transactions | 2 | Aug 23, 2024 |